Full wwPDB EM Validation Report O i...N.; Aebersold, R.; Ban, N. Deposited on : 2014-09-25...
Transcript of Full wwPDB EM Validation Report O i...N.; Aebersold, R.; Ban, N. Deposited on : 2014-09-25...
-
Full wwPDB EM Validation Report iO
Dec 6, 2020 � 01:06 am GMT
PDB ID : 4V1AEMDB ID : EMD-2787
Title : Structure of the large subunit of the mammalian mitoribosome, part 2 of 2Authors : Greber, B.J.; Boehringer, D.; Leibundgut, M.; Bieri, P.; Leitner, A.; Schmitz,
N.; Aebersold, R.; Ban, N.Deposited on : 2014-09-25Resolution : 3.40 Å(reported)
This is a Full wwPDB EM Validation Report for a publicly released PDB entry.
We welcome your comments at [email protected] user guide is available at
https://www.wwpdb.org/validation/2017/EMValidationReportHelpwith speci�c help available everywhere you see the iO symbol.
The following versions of software and data (see references iO) were used in the production of this report:
EMDB validation analysis : 0.0.0.dev61MolProbity : 4.02b-467
Percentile statistics : 20191225.v01 (using entries in the PDB archive December 25th 2019)Ideal geometry (proteins) : Engh & Huber (2001)
Ideal geometry (DNA, RNA) : Parkinson et al. (1996)Validation Pipeline (wwPDB-VP) : 2.15.1
https://www.wwpdb.org/validation/2017/EMValidationReportHelphttps://www.wwpdb.org/validation/2017/EMValidationReportHelphttps://www.wwpdb.org/validation/2017/EMValidationReportHelphttps://www.wwpdb.org/validation/2017/EMValidationReportHelp#references
-
Page 2 Full wwPDB EM Validation Report EMD-2787, 4V1A
1 Overall quality at a glance iO
The following experimental techniques were used to determine the structure:ELECTRON MICROSCOPY
The reported resolution of this entry is 3.40 Å.
Percentile scores (ranging between 0-100) for global validation metrics of the entry are shown inthe following graphic. The table shows the number of entries on which the scores are based.
MetricWhole archive(#Entries)
EM structures(#Entries)
Clashscore 158937 4297Ramachandran outliers 154571 4023
Sidechain outliers 154315 3826
The table below summarises the geometric issues observed across the polymeric chains and their �tto the map. The red, orange, yellow and green segments of the bar indicate the fraction of residuesthat contain outliers for >=3, 2, 1 and 0 types of geometric quality criteria respectively. A greysegment represents the fraction of residues that are not modelled. The numeric value for eachfraction is indicated below the corresponding segment, with a dot representing fractions
-
Page 3 Full wwPDB EM Validation Report EMD-2787, 4V1A
Continued from previous page...
Mol Chain Length Quality of chain
9 i 312
10 j 279
11 k 212
12 l 166
13 m 159
14 n 128
15 o 124
16 p 112
17 q 138
18 t 102
19 u 205
20 v 222
21 w 433
22 x 196
23 z 47
-
Page 4 Full wwPDB EM Validation Report EMD-2787, 4V1A
2 Entry composition iO
There are 24 unique types of molecules in this entry. The entry contains 31917 atoms, of which 0are hydrogens and 0 are deuteriums.
In the tables below, the AltConf column contains the number of residues with at least one atomin alternate conformation and the Trace column contains the number of residues modelled with atmost 2 atoms.
Molecule 1 is a protein called MITORIBOSOMAL PROTEIN ML37, MRPL37.
Mol Chain Residues Atoms AltConf Trace
1 a 393Total C N O S3173 2040 556 565 12
0 0
Molecule 2 is a protein called MITORIBOSOMAL PROTEIN ML38, MRPL38.
Mol Chain Residues Atoms AltConf Trace
2 b 354Total C N O S2952 1876 542 525 9
0 0
Molecule 3 is a protein called MITORIBOSOMAL PROTEIN ML39, MRPL39.
Mol Chain Residues Atoms AltConf Trace
3 c 295Total C N O S2408 1541 410 441 16
0 0
Molecule 4 is a protein called MITORIBOSOMAL PROTEIN ML40, MRPL40.
Mol Chain Residues Atoms AltConf Trace
4 d 99Total C N O S832 528 148 155 1
0 0
Molecule 5 is a protein called MITORIBOSOMAL PROTEIN ML41, MRPL41.
Mol Chain Residues Atoms AltConf Trace
5 e 121Total C N O S968 626 167 172 3
0 0
Molecule 6 is a protein called MITORIBOSOMAL PROTEIN ML42, MRPL42.
Mol Chain Residues Atoms AltConf Trace
6 f 108Total C N O S852 544 154 150 4
0 0
https://www.wwpdb.org/validation/2017/EMValidationReportHelp#entry_composition
-
Page 5 Full wwPDB EM Validation Report EMD-2787, 4V1A
Molecule 7 is a protein called MITORIBOSOMAL PROTEIN ML43, MRPL43.
Mol Chain Residues Atoms AltConf Trace
7 g 148Total C N O S1167 727 225 212 3
0 0
Molecule 8 is a protein called MITORIBOSOMAL PROTEIN ML44, MRPL44.
Mol Chain Residues Atoms AltConf Trace
8 h 289Total C N O S2319 1486 399 426 8
0 0
Molecule 9 is a protein called MITORIBOSOMAL PROTEIN ML45, MRPL45.
Mol Chain Residues Atoms AltConf Trace
9 i 242Total C N O S1979 1266 352 351 10
0 0
Molecule 10 is a protein called MITORIBOSOMAL PROTEIN ML46, MRPL46.
Mol Chain Residues Atoms AltConf Trace
10 j 217Total C N O S1775 1137 311 321 6
0 0
Molecule 11 is a protein called MITORIBOSOMAL PROTEIN ML48, MRPL48.
Mol Chain Residues Atoms AltConf Trace
11 k 131Total C N O S1050 671 178 196 5
0 0
Molecule 12 is a protein called MITORIBOSOMAL PROTEIN ML49, MRPL49.
Mol Chain Residues Atoms AltConf Trace
12 l 133Total C N O S1097 709 192 194 2
0 0
Molecule 13 is a protein called MITORIBOSOMAL PROTEIN ML50, MRPL50.
Mol Chain Residues Atoms AltConf Trace
13 m 109Total C N O S893 568 160 162 3
0 0
Molecule 14 is a protein called MITORIBOSOMAL PROTEIN ML51, MRPL51.
-
Page 6 Full wwPDB EM Validation Report EMD-2787, 4V1A
Mol Chain Residues Atoms AltConf Trace
14 n 97Total C N O S837 539 166 128 4
0 0
Molecule 15 is a protein called MITORIBOSOMAL PROTEIN ML52, MRPL52.
Mol Chain Residues Atoms AltConf Trace
15 o 94Total C N O S747 466 143 136 2
0 0
Molecule 16 is a protein called MITORIBOSOMAL PROTEIN ML53, MRPL53.
Mol Chain Residues Atoms AltConf Trace
16 p 97Total C N O S742 459 143 134 6
0 0
Molecule 17 is a protein called MITORIBOSOMAL PROTEIN ML54, MRPL54.
Mol Chain Residues Atoms AltConf Trace
17 q 37Total C N O336 214 69 53
0 0
Molecule 18 is a protein called MITORIBOSOMAL PROTEIN ML63, MRPL57, MRP63.
Mol Chain Residues Atoms AltConf Trace
18 t 94Total C N O S780 485 168 126 1
0 0
Molecule 19 is a protein called MITORIBOSOMAL PROTEIN ML62, MRPL58, ICT1.
Mol Chain Residues Atoms AltConf Trace
19 u 151Total C N O S1208 748 233 222 5
0 0
Molecule 20 is a protein called MITORIBOSOMAL PROTEIN ML64, MRPL59, CRIF1.
Mol Chain Residues Atoms AltConf Trace
20 v 131Total C N O S1068 662 206 195 5
0 0
Molecule 21 is a protein called MITORIBOSOMAL PROTEIN ML65, MRPS30.
-
Page 7 Full wwPDB EM Validation Report EMD-2787, 4V1A
Mol Chain Residues Atoms AltConf Trace
21 w 387Total C N O S3126 2011 548 555 12
0 0
Molecule 22 is a protein called MITORIBOSOMAL PROTEIN ML66, MRPS18A.
Mol Chain Residues Atoms AltConf Trace
22 x 162Total C N O S1325 845 249 224 7
0 0
Molecule 23 is a protein called UNASSIGNED SECONDARY STRUCTURE ELEMENTS.
Mol Chain Residues Atoms AltConf Trace
23 z 47Total C N O282 188 47 47
0 0
Molecule 24 is ZINC ION (three-letter code: ZN) (formula: Zn).
Mol Chain Residues Atoms AltConf
24 x 1Total Zn1 1
0
-
Page 8 Full wwPDB EM Validation Report EMD-2787, 4V1A
3 Residue-property plots iO
These plots are drawn for all protein, RNA, DNA and oligosaccharide chains in the entry. The�rst graphic for a chain summarises the proportions of the various outlier classes displayed in thesecond graphic. The second graphic shows the sequence view annotated by issues in geometry andatom inclusion in map density. Residues are color-coded according to the number of geometricquality criteria for which they contain at least one outlier: green = 0, yellow = 1, orange = 2and red = 3 or more. A red diamond above a residue indicates a poor �t to the EM map forthis residue (all-atom inclusion < 40%). Stretches of 2 or more consecutive residues without anyoutlier are shown as a green connector. Residues present in the sample, but not in the model, areshown in grey.
• Molecule 1: MITORIBOSOMAL PROTEIN ML37, MRPL37
Chain a:
MET
ALA
LEU
ALA
SER
GLY
PRO
ALA
ARG
ARG
ALA
LEU
ALA
ARG
PRO
GLY
ARG
LEU
GLY
PHE
GLY
GLY
CYS
GLY
ALA
PRO
ARG
ARG
GLY
A30
V35
K40
�
P43
�
E56
�
E95
�
L113
E148�
D151�
T175
D182�
H195
N207
S210
S225
E244�
T248
E254�
C268
N269
V270
N274
T277
V335
D348
E368�
K393�
V398
A422
VAL
• Molecule 2: MITORIBOSOMAL PROTEIN ML38, MRPL38
Chain b:
MET
ALA
ALA
PRO
TRP
TRP
ARG
ALA
ALA
LEU
CYS
ALA
SER
ARG
ARG
TRP
ARG
GLY
PHE
SER
THR
SER
ALA
ALA
LEU
SER
R27
D39
�
S53
G79
�E80
�E81
�S82
�G83
�P84
�K85
�D86
�R87
�
G91
�
S98
�
E118�
Q126�
C143
L157
D160�
L173
G180�
E181�
D182�
E207�
A208�
D209�
E210�
G211�
L226�
D229�
V237
E247�
R267
K277�
R278�
I279
D280�
F281
S282�
S288
P289�
D302�
C321
D324
Y350
R360
D371�
S372
H373�
E374�
Y380
• Molecule 3: MITORIBOSOMAL PROTEIN ML39, MRPL39
Chain c:
MET
ALA
MET
GLY
ALA
TRP
GLY
LEU
ARG
LEU
TRP
ARG
ALA
VAL
PRO
ARG
GLY
GLU
ALA
GLY
TRP
ARG
LEU
ILE
ALA
THR
SER
PRO
ALA
S30
�Q31
�L32
�S33
�
S54
�L55
T56
�P57
R58
�
R98
�
D106
G107�
D129�
D130
D131�
W140
C149
E152�
D157�
E158�
E188�
E194�
Y208�
K209
D210�
L211
K221�
V222
G263�
C272
V280
L283�
Q284�
T285
Q286�
S287�
N310
E322�
D323�
K324�
THR
LYS
PRO
THR
GLU
GLU
SER
ALA
SER
THR
• Molecule 4: MITORIBOSOMAL PROTEIN ML40, MRPL40
Chain d:
https://www.wwpdb.org/validation/2017/EMValidationReportHelp#residue_plots
-
Page 9 Full wwPDB EM Validation Report EMD-2787, 4V1A
MET
ALA
ALA
ALA
ALA
LEU
GLY
ALA
ALA
SER
ARG
THR
LEU
ARG
PRO
ALA
SER
ARG
LEU
VAL
GLY
ALA
TRP
PRO
THR
GLN
THR
ARG
ASP
ALA
HIS
GLU
ARG
GLY
SER
LEU
PHE
SER
PHE
TRP
GLY
LEU
VAL
PRO
MET
ARG
ALA
GLU
PRO
LEU
ARG
LYS
LYS
LYS
LYS
VAL
ASP
PRO
LYS
LYS
ASP
GLN
ALA
ALA
LYS
ASP
ARG
LEU
LYS
LYS
ARG
ILE
ARG
ARG
LEU
GLU
LYS
ALA
SER
GLN
GLU
LEU
I83
�P84
�I85
�E86
�D87
�F88
�I89
�T90
�P91
�V92
�K93
�F94
�L95
�N96
�K97
�E98
�R99
�Q100�
R101
P102�
P103�
V104�
E105�
L106�
P107
F108�
E109�
R127�
E130�
S134�
A135�
I136
L139
L140
E141�
E144�
L147�
Q148�
E149�
L150
R151�
L152�
S153�
S154
P155�
E156�
L157
H158�
A159�
E160
A161�
T162
K163�
S167�
L168�
F169�
P170
F171�
E172
R173�
Q174
G175�
P176�
D177�
P180
P181
ILE
SER
ASP
TYR
GLN
PRO
PRO
GLU
GLY
ARG
TYR
GLN
ASP
ILE
THR
LYS
VAL
TYR
THR
GLN
VAL
GLU
PHE
LYS
LYS
• Molecule 5: MITORIBOSOMAL PROTEIN ML41, MRPL41
Chain e:
MET
GLY
LEU
LEU
SER
GLY
ALA
ALA
ARG
ALA
LEU
VAL
ARG
GLY
A15
S19
D45
�
G65
�F66
E78
�G79
�
K103�
A104�
G105
T106�
F107
D108�
H111
L112
E113�
K114�
E118�
Q127
R135
• Molecule 6: MITORIBOSOMAL PROTEIN ML42, MRPL42
Chain f:
MET
ALA
LEU
ALA
ALA
VAL
LYS
TRP
VAL
ILE
SER
SER
ARG
THR
ILE
LEU
LYS
HIS
LEU
PHE
PRO
ILE
GLN
ASN
SER
ALA
SER
TYR
CYS
VAL
CYS
HIS
LYS
SER
T35
�
N44
V59
S64
V65
D66
�
T72
X78
�X79
�X80
�X81
�X82
�X83
�X84
�
X89
�X90
�X91
�X92
�X93
�X94
�
X95
�X96
�X97
�X98
�X99
�X100�
E101�
H102�
L103�
K120
H121
R122
R131
K140�
D141�
R142�
• Molecule 7: MITORIBOSOMAL PROTEIN ML43, MRPL43
Chain g:
MET
T2
T6
R9
V14
R21
R28
L33
S34
S39
R49
�
C70
V94
S108
V112
I113
R114
I126
T138
Q149�
ASP
PRO
ALA
PRO
ALA
GLN
VAL
GLN
ALA
GLN
• Molecule 8: MITORIBOSOMAL PROTEIN ML44, MRPL44
Chain h:
MET
ALA
SER
GLY
LEU
VAL
ARG
LEU
LEU
GLN
TRP
GLY
PRO
ARG
ARG
LEU
LEU
ALA
PRO
ALA
ALA
PRO
THR
LEU
ALA
PRO
PRO
VAL
ARG
GLY
A31
�K32
�K33
�
L51
�R52
�
P55
�
R78
L88
I98
E102�
R105�
Q106�
K107�
L108�
G109�
I110�
D111�
K112�
E113�
A114�
A115�
L116�
L117�
N118�
S133
L148
C167
R171
S181
L191
R192
T211
R216
E230�
M231
W232
K249�
D277�
T288
L301
K318�
P319�
LYS
GLU
HIS
VAL
ARG
ALA
GLU
LYS
THR
ILE
THR
ALA
SER
-
Page 10 Full wwPDB EM Validation Report EMD-2787, 4V1A
• Molecule 9: MITORIBOSOMAL PROTEIN ML45, MRPL45
Chain i:
MET
ALA
ALA
PRO
VAL
THR
ARG
GLY
LEU
SER
CYS
LEU
PRO
ARG
VAL
LEU
GLY
TRP
TRP
SER
ARG
GLN
PRO
VAL
LEU
VAL
THR
GLN
SER
THR
ALA
VAL
VAL
PRO
VAL
ARG
THR
LYS
LYS
ARG
PHE
THR
PRO
PRO
THR
TYR
GLN
PRO
LYS
TYR
LYS
SER
GLU
LYS
GLU
F56�
V57�
E58�
H59�
A60�
R61
�K62
�A63
�G64
�L65
�V66
�I67
�P68
�H69
�E70
�R71
�L72
�E73
�R74
P75
�I76
�H77
�L78
A79
�C80
T81
�A82
�G83
I84
�
V89
�
E92
�G93
�D94
A95
�R96
�I97
�S98
�S99
�L100�
S101�
K102�
E103�
G104�
L105�
A106�
Q107�
R108�
A109�
E110�
R111�
L112�
K113�
K114�
N115�
V116�
Q119�
L120�
S121
I122�
R123�
K124
I125�
R126�
E127�
S128�
D129�
P130�
N131�
F132�
K133�
I134
K135�
D136�
F137�
P138
E139�
K140�
A141�
K142
D143�
I146�
E147�
C151
T165
E166
N167�
M172�
I176�
R177�
E187�
S188�
L189�
E190�
R198�
C199�
S200�
S201�
L202�
M203�
N204�
Q205�
G206�
N207�
I208�
R215
E236�
D237�
R240�
D241�
E244�
Y245�
L252�
V253
D254�
P255�
Y256�
G257�
S258
K264�
I265�
I266�
W269�
A270�
P271
P272�
P285�
Q286�
L287�
K288�
P289
W290�
E291�
E292�
F293�
E294�
E295�
P296�
Q297�
GLY
GLU
VAL
HIS
LYS
PRO
GLN
PRO
ALA
ARG
ARG
ARG
ASN
ASP
SER
• Molecule 10: MITORIBOSOMAL PROTEIN ML46, MRPL46
Chain j:
MET
ALA
ALA
PRO
VAL
ARG
ARG
THR
MET
LEU
ARG
VAL
VAL
ARG
GLY
TRP
ARG
ARG
PHE
GLU
GLY
PRO
TRP
ALA
HIS
SER
LEU
GLY
SER
ARG
ASN
LEU
ALA
LEU
ALA
VAL
ALA
PRO
SER
SER
SER
SER
S43
�P44
�W45
�R46
�
A50
�L51
�C52
�L53
�Q54
R55
K61
�P62
�L63
�T64
P65
�
E69
�
R81
�
Y84
R90
�A91
L92
�D93
�E94
A95
�Q96
�Q97
�L98
�A99
�K100�
K101�
K102�
S103�
D104�
LEU
TYR
GLU
GLU
GLU
ASP
GLU
GLN
ASN
ILE
LEU
L116�
A117
Q118�
K127�
H130�
F131�
K132�
L133�
G134
A135�
R136�
L137�
T138
E139�
A140�
D141�
K142
K143�
D144�
D145�
R146�
L149�
H150
R151
I158�
L159�
E163�
K164�
L165�
G166�
D167�
Q168�
D169�
I170�
W171�
M172�
L173�
S176�
D177
W178�
Q179
P180�
G181�
E182�
R185�
T191�
L192�
L195�
S196�
N199�
M200�
E201�
A202�
L205�
A208�
H212�
Y213�
K214�
F215
K216�
F217�
PRO
GLN
ALA
MET
ARG
THR
GLU
THR
SER
L227
K230�
V231
F232�
F233�
F234
K235�
A236
L237�
G241�
D242�
F243
S244�
Q245�
A246�
G247�
K248�
K249�
G250�
V255
S256
K257�
E258�
E259�
L260
G261�
D262�
Y263
L264�
K265�
P266�
K267�
Y268
L269�
A270
Q271�
V272
R273�
R274
F275
L276
L277�
D278�
L279�
• Molecule 11: MITORIBOSOMAL PROTEIN ML48, MRPL48
Chain k:
MET
ASN
GLY
ALA
LEU
GLY
LYS
ALA
LEU
CYS
LEU
ARG
ASN
ASP
THR
VAL
LEU
LYS
GLN
ALA
LEU
SER
LEU
ILE
ARG
VAL
ARG
ALA
SER
GLY
GLU
SER
PRO
ILE
CYS
SER
ALA
GLY
GLY
ILE
LEU
LEU
SER
THR
SER
ARG
HIS
Y48
Q66
�GLU
PRO
LYS
LYS
LYS
LYS
GLY
LYS
VAL
GLU
V77
�R78
�P79
�I80
�N81
�L82
�G83
�T84
�D85
�Y86
E87
�Y88
�
L91
�
A97
�Y98
�D99
�
E122�
A126�
M127�
K130�
T131
M132�
E133�
V134
L135�
Q136�
L137
Q138�
GLU
GLN
GLY
SER
LYS
M144�
F145�
L146�
D147�
A148�
V149�
L150�
T151�
T152
H153�
S160�
G161
L162
S163�
F166�
A167�
E168�
I169�
I173�
-
Page 11 Full wwPDB EM Validation Report EMD-2787, 4V1A
E180�
G181
V182�
K183�
R187�
E188
H189�
T190
E191�
E192�
D193�
PHE
LYS
GLY
ARG
PHE
LYS
ALA
ARG
PRO
GLU
LEU
GLU
GLU
LEU
LEU
ALA
LYS
LEU
ASN
• Molecule 12: MITORIBOSOMAL PROTEIN ML49, MRPL49
Chain l:
MET
ALA
ALA
THR
VAL
LEU
CYS
GLY
VAL
LEU
ARG
ALA
TRP
ARG
THR
GLY
VAL
PRO
LEU
GLY
CYS
GLY
LEU
ARG
ARG
LEU
SER
GLN
THR
GLN
GLY
THR
PRO
E34
�Y35
�
R59
�
E64
�
D77
�
S89
R90
N93
D99
I100
T101
N141
F166
• Molecule 13: MITORIBOSOMAL PROTEIN ML50, MRPL50
Chain m:
MET
ALA
ALA
ARG
TRP
VAL
SER
GLY
LEU
ALA
ARG
ARG
SER
LEU
THR
CYS
ALA
VAL
SER
GLY
ALA
PRO
ARG
ARG
GLU
PHE
TRP
SER
PRO
PHE
ARG
LYS
GLU
LYS
GLN
PRO
VAL
VAL
ALA
GLU
THR
VAL
GLU
GLU
VAL
LYS
LYS
GLU
PRO
ILE
L51
�V52
�
P55
�I56
Q57
�S58
�R59
�
E65
�
E77
�
G80
�S81
�S82
�V83
�P84
S85
�
I90
L97
�
R104�
D108�
M121
R125�
D137�
D142�
N148�
Y159
• Molecule 14: MITORIBOSOMAL PROTEIN ML51, MRPL51
Chain n:
MET
ALA
GLY
SER
LEU
SER
TRP
VAL
THR
GLY
ARG
GLY
LEU
TRP
GLY
GLN
LEU
PRO
LEU
THR
CYS
ARG
SER
PHE
SER
LEU
GLY
ILE
PRO
ARG
LEU
F32
K42
�
R46
V56
N65
F66
I92
V98
R101
D105
R128
• Molecule 15: MITORIBOSOMAL PROTEIN ML52, MRPL52
Chain o:
MET
ALA
ALA
TRP
GLY
ILE
LEU
LEU
SER
THR
GLY
VAL
ARG
ARG
LEU
HIS
CYS
GLY
THR
ALA
ALA
GLN
A23
Y40
L43
T44
D48
D53
�
R65
R76
E97
�K98
L99
�Q100�
E103�
K107�
K113�
L116�
LEU
GLN
ASN
PRO
GLN
PRO
SER
GLN
• Molecule 16: MITORIBOSOMAL PROTEIN ML53, MRPL53
Chain p:
MET
A2
�A3
�A4
�L5
�A6
�R7
�L8
�G9
�L10
�R11
�
K14
�
E24
�K25
�N26
�V27
�
A36
�V37
�S38
�
K41
�V42
R43
�C44
�T45
�N46
�L47
�N48
�C49
�S50
�V51
�
D54
�V55
R56
�H57
D58
�G59
S60
�E61
�
F68
�G69
D70
�G71
�H72
�R73
�L74
�
H80
�
E85
�M86
L87
�
A91
�S92
�
H93
I94�
Q95�
A96�
R97�
G98�
ALA
ALA
GLY
SER
GLY
ASP
LYS
PRO
SER
ALA
SER
THR
GLY
ARG
• Molecule 17: MITORIBOSOMAL PROTEIN ML54, MRPL54
-
Page 12 Full wwPDB EM Validation Report EMD-2787, 4V1A
Chain q:
MET
ALA
ALA
ARG
ARG
LEU
PHE
GLY
ALA
ALA
ARG
SER
TRP
ALA
ALA
TRP
ARG
ALA
TRP
GLU
LEU
SER
ASP
ALA
ALA
VAL
SER
GLY
ARG
LEU
HIS
VAL
ARG
ASN
TYR
ALA
LYS
ARG
PRO
VAL
ILE
LYS
GLY
GLY
LYS
GLY
GLY
LYS
GLY
ALA
VAL
VAL
GLY
GLU
ALA
LEU
LYS
ASP
PRO
GLU
VAL
CYS
THR
ASP
PRO
PHE
ARG
LEU
THR
THR
HIS
ALA
MET
GLY
VAL
ASN
ILE
TYR
LYS
GLU
GLY
GLN
ASP
VAL
VAL
LEU
LYS
PRO
ASP
SER
GLU
TYR
PRO
GLU
TRP
LEU
PHE
GLU
MET
ASN
VAL
G102�
P103
P104�
K105�
K106�
E109�
L110
D111�
P112
E113�
N135�
R136�
K137�
F138�
• Molecule 18: MITORIBOSOMAL PROTEIN ML63, MRPL57, MRP63
Chain t:
MET
PHE
LEU
THR
ALA
LEU
LEU
ARG
R9
R25
N45
L49
S50
R51
F82
R86
E90
�
K100�
W101
S102�
• Molecule 19: MITORIBOSOMAL PROTEIN ML62, MRPL58, ICT1
Chain u:
MET
ALA
ALA
ALA
ARG
CYS
LEU
ARG
TRP
GLY
LEU
ASN
ARG
ALA
GLY
ALA
TRP
LEU
LEU
PRO
SER
PRO
THR
ARG
TYR
PRO
ARG
ARG
ALA
LEU
HIS
LYS
GLN
VAL
GLU
GLY
THR
E38
�
D46
�K47
�
R53
�G54
�S55
D56
�
L61
�P62
D63
�D64
�A65
�K66
�Q67
�A68
�N69
�
D74
�R75
�
S79
R82
�S83
�S84
�G85
�PRO
GLY
GLY
GLN
ASN
VAL
ASN
K93
�V94
�N95
�S96
�K97
�
H103�
L104
A105�
S106�
A107�
D108�
A111�
K123
N124
R125�
R128�
S129�
L132�
E137
R140�
D148�
D155�
S161�
Q162�
P163�
X164�
X165�
X166�
X167�
X168�
X169�
X170�
X171�
X172�
X173�
L174�
R175�
R176�
S177�
R178�
I179�
E180�
N181�
M182�
N183�
R184�
E185�
R186�
L187�
R188�
K189�
K190�
R191�
I192�
S193�
S194�
A195�
ILE
LYS
THR
SER
ARG
ARG
VAL
ASP
VAL
ASP
• Molecule 20: MITORIBOSOMAL PROTEIN ML64, MRPL59, CRIF1
Chain v:
MET
ALA
ALA
PRO
VAL
GLN
GLN
ALA
ARG
THR
LEU
LEU
ARG
LEU
VAL
THR
THR
LEU
GLY
GLN
GLY
SER
ARG
GLY
Y25
D43
�D44
�
S53
P54
R55
�
H64
S68
R83
�
R90
�
E101�
S102
L103�
R104�
V105�
Q106�
Q107�
L108�
A109�
E110�
E111�
Q112�
K113�
R114�
Q115�
A116�
R117�
E118�
Q119�
L120�
I121�
E122�
E123�
C124�
M125�
A126�
K127�
M128�
P129�
Q130�
M131�
I132�
E133�
N134�
W135�
R136�
Q137�
Q138�
Q139�
Q140�
E141�
R142�
R143�
X144�
X145�
X146�
X147�
X148�
X149�
X150�
X151�
X152�
X153�
X154�
X155�
LEU
GLN
ALA
GLU
ALA
GLN
GLU
ARG
LEU
GLY
TYR
HIS
VAL
ASP
PRO
ARG
SER
ALA
ARG
PHE
GLN
GLU
LEU
LEU
GLN
ASP
MET
GLU
LYS
GLN
HIS
ARG
LYS
ARG
LEU
LYS
GLU
GLU
LYS
GLN
ARG
LYS
LYS
LYS
GLU
ALA
ARG
ALA
ALA
ALA
MET
ALA
ALA
ALA
ALA
ALA
GLN
ASP
PRO
ALA
ASP
SER
GLU
THR
PRO
SER
SER
• Molecule 21: MITORIBOSOMAL PROTEIN ML65, MRPS30
Chain w:
-
Page 13 Full wwPDB EM Validation Report EMD-2787, 4V1A
MET
ALA
ALA
ALA
ARG
CYS
ARG
ARG
PHE
PRO
LEU
ARG
GLY
ALA
GLY
LEU
SER
LEU
HIS
THR
ALA
ALA
LYS
ALA
ALA
VAL
THR
ALA
PRO
GLU
VAL
THR
GLY
PRO
ASP
VAL
PRO
ALA
THR
P40
R59
R81
L100
N104
T121�
P122�
A123�
K124�
L125�
E126�
P127�
E128�
I133�
K155�
R156�
A157�
P158�
V159�
I160�
Q161�
D162�
R163�
E164�
A165
I166
D195�
L205
E209�
R236
V245
D263
L267
Q271
N274
C287
D298�
M335
D357
G358
L395
I399
V404
K405
L420
N421
D426
LYS
SER
GLN
LEU
LEU
GLU
ASN
• Molecule 22: MITORIBOSOMAL PROTEIN ML66, MRPS18A
Chain x:
MET
VAL
GLY
LEU
ASN
VAL
LEU
VAL
SER
GLY
CYS
GLY
ARG
LEU
LEU
ARG
GLY
LEU
LEU
ALA
GLY
PRO
ALA
ALA
THR
SER
TRP
ALA
ARG
PRO
PRO
SER
ARG
GLY
F35
�R36
E37
�
E40
�I41
�L42
�D43
�G44
�K45
�T46
�T47
�I48
�
R52
�I53
T54
E55
�T56
C70
P71
I72
F92
I93
E111
I115
C118
M121
K134�
L135
P136�
E137�
G138�
F139�
V140
P141�
K142�
S143
K144�
R149
D183�
H196
• Molecule 23: UNASSIGNED SECONDARY STRUCTURE ELEMENTS
Chain z:
X9
�X10
�X11
�X12
�X13
�X14
�X15
�X16
�X17
�X18
�X19
�X20
�X21
�X22
�X23
�X24
�X25
�X26
�X27
�X28
�X29
�X30
�X31
�X32
�X33
�X34
�X35
�X36
�X99
�X100�
X101
X102�
X103�
X104�
X105�
X106
X201�
X202�
X203�
X204�
X205�
X206�
X207�
X208�
X209�
X210�
X211�
-
Page 14 Full wwPDB EM Validation Report EMD-2787, 4V1A
4 Experimental information iO
Property Value SourceEM reconstruction method SINGLE PARTICLE DepositorImposed symmetry POINT, C1 DepositorNumber of particles used 141675 DepositorResolution determination method Not providedCTF correction method PER DETECTOR FRAME DepositorMicroscope FEI TITAN KRIOS DepositorVoltage (kV) 300 DepositorElectron dose (e−/Å
2) 20 Depositor
Minimum defocus (nm) 800 DepositorMaximum defocus (nm) 3000 DepositorMagni�cation 100000 DepositorImage detector FEI FALCON II (4k x 4k) DepositorMaximum map value 0.560 DepositorMinimum map value -0.257 DepositorAverage map value 0.004 DepositorMap value standard deviation 0.025 DepositorRecommended contour level 0.07 DepositorMap size (Å) 302.4, 302.4, 302.4 wwPDBMap dimensions 216, 216, 216 wwPDBMap angles (◦) 90.0, 90.0, 90.0 wwPDBPixel spacing (Å) 1.4, 1.4, 1.4 Depositor
https://www.wwpdb.org/validation/2017/EMValidationReportHelp#experimental_info
-
Page 15 Full wwPDB EM Validation Report EMD-2787, 4V1A
5 Model quality iO
5.1 Standard geometry iO
Bond lengths and bond angles in the following residue types are not validated in this section:ZN
The Z score for a bond length (or angle) is the number of standard deviations the observed valueis removed from the expected value. A bond length (or angle) with |Z| > 5 is considered anoutlier worth inspection. RMSZ is the root-mean-square of all Z scores of the bond lengths (orangles).
Mol ChainBond lengths Bond anglesRMSZ #|Z| >5 RMSZ #|Z| >5
1 a 0.34 0/3267 0.53 0/44552 b 0.36 0/3047 0.55 0/41393 c 0.33 0/2464 0.50 0/33304 d 0.38 0/853 0.56 1/1153 (0.1%)5 e 0.37 0/996 0.56 0/13406 f 0.38 0/731 0.54 0/9907 g 0.38 0/1191 0.58 0/16148 h 0.35 0/2372 0.53 0/32119 i 0.32 0/2034 0.52 0/275910 j 0.34 0/1811 0.56 0/243611 k 0.35 0/1070 0.55 0/144812 l 0.38 0/1135 0.53 0/154913 m 0.30 0/917 0.49 0/124814 n 0.44 0/860 0.60 0/115015 o 0.39 0/762 0.52 0/102216 p 0.34 0/752 0.53 0/101317 q 0.29 0/346 0.47 0/46318 t 0.41 0/798 0.61 0/107319 u 0.31 0/1163 0.49 0/155720 v 0.33 0/1022 0.44 0/138221 w 0.39 0/3206 0.55 0/435422 x 0.36 0/1364 0.62 0/1849All All 0.36 0/32161 0.54 1/43535 (0.0%)
Chiral center outliers are detected by calculating the chiral volume of a chiral center and verifying ifthe center is modelled as a planar moiety or with the opposite hand.A planarity outlier is detectedby checking planarity of atoms in a peptide group, atoms in a mainchain group or atoms of asidechain that are expected to be planar.
Mol Chain #Chirality outliers #Planarity outliers2 b 0 1
Continued on next page...
https://www.wwpdb.org/validation/2017/EMValidationReportHelp#model_qualityhttps://www.wwpdb.org/validation/2017/EMValidationReportHelp#standard_geometry
-
Page 16 Full wwPDB EM Validation Report EMD-2787, 4V1A
Continued from previous page...
Mol Chain #Chirality outliers #Planarity outliers10 j 0 114 n 0 121 w 0 1All All 0 4
There are no bond length outliers.
All (1) bond angle outliers are listed below:
Mol Chain Res Type Atoms Z Observed(o) Ideal(o)4 d 180 PRO C-N-CD -5.25 109.05 120.60
There are no chirality outliers.
All (4) planarity outliers are listed below:
Mol Chain Res Type Group2 b 210 GLU Peptide10 j 173 LEU Peptide14 n 65 ASN Peptide21 w 357 ASP Peptide
5.2 Too-close contacts iO
In the following table, the Non-H and H(model) columns list the number of non-hydrogen atomsand hydrogen atoms in the chain respectively. The H(added) column lists the number of hydrogenatoms added and optimized by MolProbity. The Clashes column lists the number of clashes withinthe asymmetric unit, whereas Symm-Clashes lists symmetry-related clashes.
Mol Chain Non-H H(model) H(added) Clashes Symm-Clashes1 a 3173 0 3153 0 02 b 2952 0 2840 0 03 c 2408 0 2415 0 04 d 832 0 828 0 05 e 968 0 968 0 06 f 852 0 834 0 07 g 1167 0 1173 0 08 h 2319 0 2332 0 09 i 1979 0 1974 0 010 j 1775 0 1797 0 011 k 1050 0 1044 0 012 l 1097 0 1080 0 0
Continued on next page...
https://www.wwpdb.org/validation/2017/EMValidationReportHelp#close_contacts
-
Page 17 Full wwPDB EM Validation Report EMD-2787, 4V1A
Continued from previous page...
Mol Chain Non-H H(model) H(added) Clashes Symm-Clashes13 m 893 0 878 0 014 n 837 0 860 0 015 o 747 0 748 0 016 p 742 0 749 0 017 q 336 0 342 0 018 t 780 0 792 0 019 u 1208 0 1227 0 020 v 1068 0 1034 0 021 w 3126 0 3153 0 022 x 1325 0 1354 0 023 z 282 0 294 0 024 x 1 0 0 0 0All All 31917 0 31869 0 0
The all-atom clashscore is de�ned as the number of clashes found per 1000 atoms (includinghydrogen atoms). The all-atom clashscore for this structure is 12.
There are no clashes within the asymmetric unit.
There are no symmetry-related clashes.
5.3 Torsion angles iO
5.3.1 Protein backbone iO
In the following table, the Percentiles column shows the percent Ramachandran outliers of thechain as a percentile score with respect to all PDB entries followed by that with respect to all EMentries.
The Analysed column shows the number of residues for which the backbone conformation wasanalysed, and the total number of residues.
Mol Chain Analysed Favoured Allowed Outliers Percentiles
1 a 391/423 (92%) 375 (96%) 16 (4%) 0 100 100
2 b 352/380 (93%) 329 (94%) 23 (6%) 0 100 100
3 c 293/334 (88%) 279 (95%) 14 (5%) 0 100 100
4 d 97/206 (47%) 92 (95%) 5 (5%) 0 100 100
5 e 119/135 (88%) 115 (97%) 4 (3%) 0 100 100
6 f 82/142 (58%) 81 (99%) 1 (1%) 0 100 100
7 g 146/159 (92%) 141 (97%) 5 (3%) 0 100 100Continued on next page...
https://www.wwpdb.org/validation/2017/EMValidationReportHelp#torsion_angleshttps://www.wwpdb.org/validation/2017/EMValidationReportHelp#protein_backbone
-
Page 18 Full wwPDB EM Validation Report EMD-2787, 4V1A
Continued from previous page...
Mol Chain Analysed Favoured Allowed Outliers Percentiles
8 h 287/332 (86%) 270 (94%) 17 (6%) 0 100 100
9 i 240/312 (77%) 230 (96%) 10 (4%) 0 100 100
10 j 211/279 (76%) 200 (95%) 9 (4%) 2 (1%) 17 49
11 k 125/212 (59%) 119 (95%) 6 (5%) 0 100 100
12 l 131/166 (79%) 127 (97%) 4 (3%) 0 100 100
13 m 107/159 (67%) 101 (94%) 6 (6%) 0 100 100
14 n 95/128 (74%) 91 (96%) 4 (4%) 0 100 100
15 o 92/124 (74%) 87 (95%) 5 (5%) 0 100 100
16 p 95/112 (85%) 90 (95%) 5 (5%) 0 100 100
17 q 35/138 (25%) 33 (94%) 2 (6%) 0 100 100
18 t 92/102 (90%) 88 (96%) 4 (4%) 0 100 100
19 u 137/205 (67%) 130 (95%) 7 (5%) 0 100 100
20 v 118/222 (53%) 116 (98%) 2 (2%) 0 100 100
21 w 385/433 (89%) 363 (94%) 20 (5%) 2 (0%) 29 61
22 x 160/196 (82%) 155 (97%) 4 (2%) 1 (1%) 25 57
All All 3790/4899 (77%) 3612 (95%) 173 (5%) 5 (0%) 54 82
All (5) Ramachandran outliers are listed below:
Mol Chain Res Type21 w 159 VAL22 x 93 ILE10 j 84 TYR10 j 151 ARG21 w 358 GLY
5.3.2 Protein sidechains iO
In the following table, the Percentiles column shows the percent sidechain outliers of the chainas a percentile score with respect to all PDB entries followed by that with respect to all EMentries.
The Analysed column shows the number of residues for which the sidechain conformation wasanalysed, and the total number of residues.
https://www.wwpdb.org/validation/2017/EMValidationReportHelp#protein_sidechains
-
Page 19 Full wwPDB EM Validation Report EMD-2787, 4V1A
Mol Chain Analysed Rotameric Outliers Percentiles
1 a 348/365 (95%) 332 (95%) 16 (5%) 27 57
2 b 310/328 (94%) 296 (96%) 14 (4%) 27 58
3 c 271/299 (91%) 260 (96%) 11 (4%) 30 59
4 d 92/181 (51%) 87 (95%) 5 (5%) 22 52
5 e 100/108 (93%) 94 (94%) 6 (6%) 19 49
6 f 80/110 (73%) 72 (90%) 8 (10%) 7 27
7 g 128/136 (94%) 113 (88%) 15 (12%) 5 20
8 h 251/284 (88%) 234 (93%) 17 (7%) 16 45
9 i 218/281 (78%) 211 (97%) 7 (3%) 39 67
10 j 190/242 (78%) 180 (95%) 10 (5%) 22 52
11 k 115/181 (64%) 111 (96%) 4 (4%) 36 65
12 l 122/147 (83%) 115 (94%) 7 (6%) 20 50
13 m 103/145 (71%) 101 (98%) 2 (2%) 57 78
14 n 88/113 (78%) 81 (92%) 7 (8%) 12 38
15 o 74/97 (76%) 68 (92%) 6 (8%) 11 38
16 p 79/88 (90%) 78 (99%) 1 (1%) 69 84
17 q 36/114 (32%) 36 (100%) 0 100 100
18 t 75/82 (92%) 67 (89%) 8 (11%) 6 24
19 u 126/169 (75%) 121 (96%) 5 (4%) 31 60
20 v 102/173 (59%) 99 (97%) 3 (3%) 42 69
21 w 340/373 (91%) 318 (94%) 22 (6%) 17 46
22 x 149/173 (86%) 139 (93%) 10 (7%) 16 46
All All 3397/4189 (81%) 3213 (95%) 184 (5%) 26 52
All (184) residues with a non-rotameric sidechain are listed below:
Mol Chain Res Type1 a 35 VAL1 a 113 LEU1 a 151 ASP1 a 175 THR1 a 195 HIS1 a 207 ASN1 a 210 SER1 a 225 SER
Continued on next page...
-
Page 20 Full wwPDB EM Validation Report EMD-2787, 4V1A
Continued from previous page...
Mol Chain Res Type1 a 248 THR1 a 268 CYS1 a 270 VAL1 a 274 ASN1 a 277 THR1 a 335 VAL1 a 348 ASP1 a 398 VAL2 b 53 SER2 b 143 CYS2 b 157 LEU2 b 173 LEU2 b 209 ASP2 b 210 GLU2 b 237 VAL2 b 267 ARG2 b 281 PHE2 b 288 SER2 b 321 CYS2 b 324 ASP2 b 350 TYR2 b 360 ARG3 c 56 THR3 c 106 ASP3 c 131 ASP3 c 140 TRP3 c 149 CYS3 c 211 LEU3 c 222 VAL3 c 272 CYS3 c 280 VAL3 c 285 THR3 c 310 ASN4 d 99 ARG4 d 136 ILE4 d 139 LEU4 d 150 LEU4 d 168 LEU5 e 19 SER5 e 66 PHE5 e 78 GLU5 e 106 THR
Continued on next page...
-
Page 21 Full wwPDB EM Validation Report EMD-2787, 4V1A
Continued from previous page...
Mol Chain Res Type5 e 111 HIS5 e 127 GLN6 f 44 ASN6 f 59 VAL6 f 64 SER6 f 72 THR6 f 103 LEU6 f 120 LYS6 f 122 ARG6 f 131 ARG7 g 6 THR7 g 9 ARG7 g 14 VAL7 g 21 ARG7 g 28 ARG7 g 33 LEU7 g 34 SER7 g 39 SER7 g 70 CYS7 g 94 VAL7 g 108 SER7 g 112 VAL7 g 114 ARG7 g 126 ILE7 g 138 THR8 h 33 LYS8 h 51 LEU8 h 78 ARG8 h 88 LEU8 h 98 ILE8 h 133 SER8 h 148 LEU8 h 167 CYS8 h 171 ARG8 h 181 SER8 h 191 LEU8 h 192 ARG8 h 211 THR8 h 216 ARG8 h 232 TRP8 h 288 THR8 h 301 LEU
Continued on next page...
-
Page 22 Full wwPDB EM Validation Report EMD-2787, 4V1A
Continued from previous page...
Mol Chain Res Type9 i 81 THR9 i 100 LEU9 i 134 ILE9 i 151 CYS9 i 165 THR9 i 215 ARG9 i 258 SER10 j 55 ARG10 j 145 ASP10 j 231 VAL10 j 255 VAL10 j 262 ASP10 j 264 LEU10 j 265 LYS10 j 274 ARG10 j 276 LEU10 j 277 LEU11 k 77 VAL11 k 98 TYR11 k 151 THR11 k 162 LEU12 l 89 SER12 l 90 ARG12 l 93 ASN12 l 99 ASP12 l 100 ILE12 l 101 THR12 l 141 ASN13 m 90 ILE13 m 121 MET14 n 46 ARG14 n 56 VAL14 n 66 PHE14 n 92 ILE14 n 98 VAL14 n 101 ARG14 n 105 ASP15 o 40 TYR15 o 43 LEU15 o 44 THR15 o 48 ASP15 o 65 ARG
Continued on next page...
-
Page 23 Full wwPDB EM Validation Report EMD-2787, 4V1A
Continued from previous page...
Mol Chain Res Type15 o 76 ARG16 p 60 SER18 t 9 ARG18 t 25 ARG18 t 45 ASN18 t 49 LEU18 t 51 ARG18 t 82 PHE18 t 86 ARG18 t 101 TRP19 u 79 SER19 u 97 LYS19 u 123 LYS19 u 137 GLU19 u 140 ARG20 v 53 SER20 v 64 HIS20 v 68 SER21 w 59 ARG21 w 81 ARG21 w 100 LEU21 w 104 ASN21 w 126 GLU21 w 162 ASP21 w 166 ILE21 w 205 LEU21 w 236 ARG21 w 245 VAL21 w 263 ASP21 w 267 LEU21 w 271 GLN21 w 274 ASN21 w 287 CYS21 w 335 MET21 w 395 LEU21 w 399 ILE21 w 404 VAL21 w 405 LYS21 w 420 LEU21 w 421 ASN22 x 54 THR22 x 56 THR
Continued on next page...
-
Page 24 Full wwPDB EM Validation Report EMD-2787, 4V1A
Continued from previous page...
Mol Chain Res Type22 x 70 CYS22 x 72 ILE22 x 92 PHE22 x 111 GLU22 x 115 ILE22 x 118 CYS22 x 121 MET22 x 149 ARG
Sometimes sidechains can be �ipped to improve hydrogen bonding and reduce clashes. All (59)such sidechains are listed below:
Mol Chain Res Type1 a 96 HIS1 a 108 HIS1 a 156 ASN1 a 223 HIS1 a 274 ASN1 a 289 HIS1 a 343 GLN1 a 360 ASN1 a 420 HIS2 b 220 ASN2 b 224 HIS2 b 266 HIS2 b 308 GLN2 b 320 GLN3 c 281 HIS3 c 294 GLN3 c 305 HIS3 c 310 ASN6 f 44 ASN6 f 121 HIS6 f 130 HIS7 g 17 ASN7 g 120 HIS7 g 131 HIS8 h 94 ASN8 h 177 GLN8 h 260 GLN9 i 115 ASN9 i 157 HIS9 i 193 GLN
Continued on next page...
-
Page 25 Full wwPDB EM Validation Report EMD-2787, 4V1A
Continued from previous page...
Mol Chain Res Type9 i 196 GLN9 i 217 HIS9 i 274 GLN11 k 61 HIS11 k 177 ASN12 l 93 ASN12 l 141 ASN13 m 107 ASN14 n 69 HIS14 n 122 ASN14 n 124 HIS15 o 63 GLN16 p 72 HIS16 p 93 HIS18 t 34 ASN18 t 45 ASN18 t 85 HIS19 u 103 HIS19 u 145 ASN21 w 101 ASN21 w 104 ASN21 w 173 GLN21 w 228 ASN21 w 233 ASN21 w 234 GLN21 w 367 GLN21 w 385 ASN22 x 164 ASN22 x 184 ASN
5.3.3 RNA iO
There are no RNA molecules in this entry.
5.4 Non-standard residues in protein, DNA, RNA chains iO
There are no non-standard protein/DNA/RNA residues in this entry.
5.5 Carbohydrates iO
There are no monosaccharides in this entry.
https://www.wwpdb.org/validation/2017/EMValidationReportHelp#rnahttps://www.wwpdb.org/validation/2017/EMValidationReportHelp#nonstandard_residues_and_ligandshttps://www.wwpdb.org/validation/2017/EMValidationReportHelp#nonstandard_residues_and_ligands
-
Page 26 Full wwPDB EM Validation Report EMD-2787, 4V1A
5.6 Ligand geometry iO
Of 1 ligands modelled in this entry, 1 is monoatomic - leaving 0 for Mogul analysis.
There are no bond length outliers.
There are no bond angle outliers.
There are no chirality outliers.
There are no torsion outliers.
There are no ring outliers.
No monomer is involved in short contacts.
5.7 Other polymers iO
There are no such residues in this entry.
5.8 Polymer linkage issues iO
The following chains have linkage breaks:
Mol Chain Number of breaks23 z 520 v 1
All chain breaks are listed below:
Model Chain Residue-1 Atom-1 Residue-2 Atom-2 Distance (Å)1 z 36:UNK C 99:UNK N 57.051 z 106:UNK C 201:UNK N 13.001 z 105:UNK C 106:UNK N 3.371 v 154:UNK C 155:UNK N 3.121 z 35:UNK C 36:UNK N 3.121 z 210:UNK C 211:UNK N 3.12
https://www.wwpdb.org/validation/2017/EMValidationReportHelp#nonstandard_residues_and_ligandshttps://www.wwpdb.org/validation/2017/EMValidationReportHelp#nonstandard_residues_and_ligandshttps://www.wwpdb.org/validation/2017/EMValidationReportHelp#polymer_linkage
-
Page 27 Full wwPDB EM Validation Report EMD-2787, 4V1A
6 Map visualisation iO
This section contains visualisations of the EMDB entry EMD-2787. These allow visual inspectionof the internal detail of the map and identi�cation of artifacts.
No raw map or half-maps were deposited for this entry and therefore no images, graphs, etc.pertaining to the raw map can be shown.
6.1 Orthogonal projections iO
6.1.1 Primary map
X Y Z
The images above show the map projected in three orthogonal directions.
6.2 Central slices iO
6.2.1 Primary map
X Index: 108 Y Index: 108 Z Index: 108
https://www.wwpdb.org/validation/2017/EMValidationReportHelp#map_visualisationhttps://www.wwpdb.org/validation/2017/EMValidationReportHelp#orthogonal_projectionshttps://www.wwpdb.org/validation/2017/EMValidationReportHelp#central_slices
-
Page 28 Full wwPDB EM Validation Report EMD-2787, 4V1A
The images above show central slices of the map in three orthogonal directions.
6.3 Largest variance slices iO
6.3.1 Primary map
X Index: 120 Y Index: 86 Z Index: 98
The images above show the largest variance slices of the map in three orthogonal directions.
6.4 Orthogonal surface views iO
6.4.1 Primary map
X Y Z
The images above show the 3D surface view of the map at the recommended contour level 0.07.These images, in conjunction with the slice images, may facilitate assessment of whether an ap-propriate contour level has been provided.
https://www.wwpdb.org/validation/2017/EMValidationReportHelp#largest_variance_sliceshttps://www.wwpdb.org/validation/2017/EMValidationReportHelp#orthogonal_views
-
Page 29 Full wwPDB EM Validation Report EMD-2787, 4V1A
6.5 Mask visualisation iO
This section was not generated. No masks/segmentation were deposited.
https://www.wwpdb.org/validation/2017/EMValidationReportHelp#masks
-
Page 30 Full wwPDB EM Validation Report EMD-2787, 4V1A
7 Map analysis iO
This section contains the results of statistical analysis of the map.
7.1 Map-value distribution iO
The map-value distribution is plotted in 128 intervals along the x-axis. The y-axis is logarithmic.A spike in this graph at zero usually indicates that the volume has been masked.
https://www.wwpdb.org/validation/2017/EMValidationReportHelp#map_analysishttps://www.wwpdb.org/validation/2017/EMValidationReportHelp#map_value_distribution
-
Page 31 Full wwPDB EM Validation Report EMD-2787, 4V1A
7.2 Volume estimate iO
The volume at the recommended contour level is 700 nm3; this corresponds to an approximatemass of 632 kDa.
The volume estimate graph shows how the enclosed volume varies with the contour level. Therecommended contour level is shown as a vertical line and the intersection between the line andthe curve gives the volume of the enclosed surface at the given level.
https://www.wwpdb.org/validation/2017/EMValidationReportHelp#volume_estimate
-
Page 32 Full wwPDB EM Validation Report EMD-2787, 4V1A
7.3 Rotationally averaged power spectrum iO
*Reported resolution corresponds to spatial frequency of 0.294 Å−1
https://www.wwpdb.org/validation/2017/EMValidationReportHelp#raps
-
Page 33 Full wwPDB EM Validation Report EMD-2787, 4V1A
8 Fourier-Shell correlation iO
This section was not generated. No FSC curve or half-maps provided.
https://www.wwpdb.org/validation/2017/EMValidationReportHelp#fsc_validation
-
Page 34 Full wwPDB EM Validation Report EMD-2787, 4V1A
9 Map-model �t iO
This section contains information regarding the �t between EMDB map EMD-2787 and PDBmodel 4V1A. Per-residue inclusion information can be found in section 3 on page 8.
9.1 Map-model overlay iO
X Y Z
The images above show the 3D surface view of the map at the recommended contour level 0.07 at50% transparency in yellow overlaid with a ribbon representation of the model coloured in blue.These images allow for the visual assessment of the quality of �t between the atomic model andthe map.
https://www.wwpdb.org/validation/2017/EMValidationReportHelp#map_model_fithttps://www.wwpdb.org/validation/2017/EMValidationReportHelp#map_model_overlay
-
Page 35 Full wwPDB EM Validation Report EMD-2787, 4V1A
9.2 Atom inclusion iO
At the recommended contour level, 80% of all backbone atoms, 66% of all non-hydrogen atoms,are inside the map.
https://www.wwpdb.org/validation/2017/EMValidationReportHelp#atom_inclusion_by_contour
Overall quality at a glanceEntry compositionResidue-property plotsExperimental informationModel qualityStandard geometryToo-close contactsTorsion anglesProtein backboneProtein sidechainsRNA
Non-standard residues in protein, DNA, RNA chainsCarbohydratesLigand geometryOther polymersPolymer linkage issues
Map visualisationOrthogonal projectionsPrimary map
Central slicesPrimary map
Largest variance slicesPrimary map
Orthogonal surface viewsPrimary map
Mask visualisation
Map analysisMap-value distributionVolume estimateRotationally averaged power spectrum
Fourier-Shell correlationMap-model fitMap-model overlayAtom inclusion